Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroids for POAF Prophylaxis After Cardiac Surgery
NCT06802432Phase 1Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2022
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of methylprednisolone in Atrial fibrillation (AFib) (2 arms), sponsored by Ain Shams University. Primary endpoint: Overall occurrence of postoperative Atrial Fibrillation at 72 hours. Started Jan 2022; status: completed.
02
Drugs
methylprednisolone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06802432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06802432.